7N9G
Crystal structure of the Abl 1b Kinase domain in complex with Dasatinib and Imatinib
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-BM |
Synchrotron site | APS |
Beamline | 22-BM |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2018-03-31 |
Detector | RAYONIX MX300-HS |
Wavelength(s) | 1.0 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 69.933, 166.879, 186.817 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 46.700 - 2.200 |
Rwork | 0.217 |
R-free | 0.25110 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2gqg |
RMSD bond length | 0.005 |
RMSD bond angle | 1.289 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0257) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.700 | 2.260 |
High resolution limit [Å] | 2.200 | 2.200 |
Rpim | 0.030 | |
Number of reflections | 55951 | 4480 |
<I/σ(I)> | 15.1 | |
Completeness [%] | 99.9 | 98.6 |
Redundancy | 8.6 | 8.7 |
CC(1/2) | 0.999 | 0.762 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 277.15 | Ammonium dihydrogen phosphate |